Cymbalta® (duloxetine) is a prescription antidepressant used to treat depression, anxiety, and some forms of chronic pain by increasing the available levels of serotonin and norepinephrine in the brain.
Cymbalta
*image for illustrative purpose only
Cymbalta
*image for illustrative purpose only
Cymbalta®, also known by its generic name, duloxetine, is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). It is approved by the United States Food and Drug Association (FDA) to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, diabetic peripheral neuropathic pain, and chronic musculoskeletal pain.
Cymbalta works by increasing the available levels of the chemicals serotonin and norepinephrine in the brain, which helps improve mood, reduce anxiety, and alleviate pain perception. It is made as a delayed-release oral capsule and is available in various dosages.
Some common side effects may include nausea, dry mouth, constipation, drowsiness, decreased appetite, and increased sweating, although many people tolerate the medication well. Serious side effects can include liver damage, serotonin syndrome, or blood pressure changes, and people with certain medical conditions, such as uncontrolled narrow-angle glaucoma or severe liver disease, may not be able to take Cymbalta.
Close monitoring by a healthcare provider is important, especially when starting the medication or adjusting the dose.
Cymbalta (duloxetine hydrochloride) is indicated for the treatment of the following conditions:
Major depressive disorder (MDD) in adults
Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older
Diabetic peripheral neuropathic pain (DPNP) in adults
Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older
Chronic musculoskeletal pain in adults
Serotonin and norepinephrine reuptake inhibitor (SNRI)
Most common adverse reactions (≥5% and at least twice the incidence of placebo-treated patients):
Adults:
Nausea
Dry mouth
Sleepiness
Constipation
Decreased appetite
Excessive sweating
Pediatric patients:
Decreased weight
Decreased appetite
Nausea
Vomiting
Fatigue
Diarrhea
The cost of Cymbalta varies depending on factors such as your insurance plan, which pharmacy you use, the dosage, and quantity. Without insurance, Cymbalta costs about $340 for a month’s supply of 60-milligram (mg) capsules, although coupons are available to bring down the price as low as about $277.
Generic duloxetine, which contains the same active ingredient as Cymbalta and works the same way, costs about $137 for the same dosage, but coupons may bring down the price as low as $4. Insurance plans may cover all or some of the cost of these medications.
On the Hers platform, duloxetine starts at $49 per month. That price includes the benefits of using the Hers telehealth platform, including free shipping and unlimited messaging with a provider.
Concomitant use of an MAOI antidepressant with Cymbalta is contraindicated
Use of Cymbalta within 14 days of stopping an MAOI antidepressant is contraindicated
In linezolid- or intravenous methylene blue-treated patients, initiation of Cymbalta is contraindicated
Drug interactions: potent inhibitors of CYP1A2, potent inhibitors of CYP2D6
Liver toxicity
Postural low blood pressure, falls, and fainting
Serotonin syndrome
Increased risk of bleeding
Severe skin reactions
Activation of mania or hypomania
Angle-closure glaucoma
Seizures
Blood pressure increases
Inhibitors of CYP1A2 or thioridazine: Avoid co-administration with Cymbalta
Low blood sodium: Can occur in association with SIADH
Glucose control in diabetes
Conditions that slow gastric emptying
Sexual dysfunction
Pregnancy: Third trimester use may increase risk for symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, hypotonia, tremor, irritability) in the neonate
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants.
Monitor for worsening and emergence of suicidal thoughts and behaviors.
As with many antidepressants, it may take several weeks to feel the therapeutic effects of Cymbalta. If you are taking the drug to treat anxiety or depression, you may feel the effects in about two to four weeks, but it may take longer if you’re taking it to manage pain.
Both Cymbalata and Xanax (alprazolam) can be used to treat anxiety, but they work differently in the body. Cymbalta is an SNRI that works by gradually increasing available levels of serotonin and norepinephrine in the brain, and it may take two to four weeks to feel the effects of the medication. Xanax is a benzodiazepine, which acts on the chemical GABA in the brain to reduce anxiety, and you may feel the effects within about 30 minutes.
Cymbalta is associated with weight loss initially because it may dampen your appetite. However, this side effect generally improves as your body adjusts to the medication, and some research suggests Cymbalta may lead to weight gain in some cases of long-term use.
The best time to take Cymbalta likely depends on how the medication affects you. There is no recommended time of day to take Cymbalta, but if you find it makes you drowsy, for example, you may want to take the medication at night. It’s always best to ask your healthcare provider about dosage and administration if you’re unsure.
*This information is from the label for brand name Cymbalta®. See the Full Prescribing Information for more complete information. Duloxetine, the active ingredient in Cymbalta, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient duloxetine.
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
American Academy of Family Physicians. (2023). Chronic pain medicines. https://familydoctor.org/chronic-pain-medicines/
Arthritis Foundation. (n.d.). Medications for treating fibromyalgia symptoms. https://www.arthritis.org/diseases/more-about/medications-for-treating-fibromyalgia-symptoms
Bounds CG, Patel P. Benzodiazepines. [Updated 2024 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470159/
Chu A, et al. (2023). Selective serotonin reuptake inhibitors. https://www.ncbi.nlm.nih.gov/books/NBK554406/
George TT, et al. (2023). Alprazolam. https://www.ncbi.nlm.nih.gov/books/NBK538165/
GoodRx. (n.d.). Cymbalta prices, coupons, and savings tips. https://www.goodrx.com/cymbalta
Moraczewski J, et al. (2023). Tricyclic antidepressants. https://www.ncbi.nlm.nih.gov/books/NBK557791/
National Library of Medicine. (2021). Alprazolam: MedlinePlus drug information. https://medlineplus.gov/druginfo/meds/a684001.html
NHS. (2022). About duloxetine. https://www.nhs.uk/medicines/duloxetine/about-duloxetine/
NHS. (2022). Side effects of duloxetine. https://www.nhs.uk/medicines/duloxetine/side-effects-of-duloxetine/
Rafiullah M, et al. (2022). Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update. https://pubmed.ncbi.nlm.nih.gov/33655879/
Sabri MA, et al. (2025). MAO inhibitors. https://pubmed.ncbi.nlm.nih.gov/32491327/
Sansone RA, et al. (2014). Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008300/
Sheffler ZM, et al. (2023). Antidepressants. https://www.ncbi.nlm.nih.gov/books/NBK538182/
US Food & Drug Administration. (2017). Cymbalta drug label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021427s049lbl.pdf
Wise TN, et al. (2006). Effects of the Antidepressant Duloxetine on Body Weight: Analyses of 10 Clinical Studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC1764530/